Insights from molecular dynamics simulations to exploit new trends for the development of improved opioid drugs

Neuroscience Letters
Marta Filizola

Abstract

Having accidental deaths from opioid overdoses almost quadrupled over the past fifteen years, there is a strong need to develop new, non-addictive medications for chronic pain to stop one of the deadliest epidemics in American history. Given their potentially fewer on-target overdosing risks and other adverse effects compared to classical opioid drugs, attention has recently shifted to opioid allosteric modulators and G protein-biased opioid agonists as likely drug candidates to prevent and/or reverse opioid overdoses. Understanding how these molecules bind and activate their receptors at an atomistic level is key to developing them into effective new therapeutics, and molecular dynamics-based strategies are contributing tremendously to this understanding.

References

Apr 2, 1999·Trends in Pharmacological Sciences·B L Kieffer
Oct 22, 2002·The Journal of Pharmacology and Experimental Therapeutics·Daniel C BroomJohn R Traynor
Jun 17, 2003·Nature Biotechnology·Jean-Pierre VilardagaMartin J Lohse
May 27, 2005·The Journal of Pharmacology and Experimental Therapeutics·Kirsten M RaehalLaura M Bohn
Nov 3, 2005·Nature Reviews. Drug Discovery·Terry Kenakin
Jan 13, 2006·British Journal of Pharmacology·Anna M LewandowiczJarmo T Laitinen
Feb 21, 2006·Naunyn-Schmiedeberg's Archives of Pharmacology·Markus KathmannEberhard Schlicker
Jun 29, 2006·The Journal of Pharmacology and Experimental Therapeutics·Jonathan D UrbanRichard B Mailman
Oct 25, 2006·The Journal of Pharmacology and Experimental Therapeutics·Richard B RothmanThomas E Prisinzano
Jul 17, 2007·Trends in Pharmacological Sciences·Richard B Mailman
May 21, 2010·Biophysical Journal·Davide Provasi, Marta Filizola
Jul 20, 2010·Neuropharmacology·Peter KeovArthur Christopoulos
Jan 1, 2009·F1000 Biology Reports·Terry Kenakin
Jan 26, 2011·Biochemistry·Jennifer M JohnstonMarta Filizola
Oct 28, 2011·Proceedings of the National Academy of Sciences of the United States of America·Ron O DrorDavid E Shaw
Mar 23, 2012·Nature·Aashish ManglikSébastien Granier
Mar 23, 2012·Nature·Huixian WuRaymond C Stevens
May 12, 2012·Molecular Pharmacology·Denise WoottenPatrick M Sexton
May 19, 2012·Nature·Sébastien GranierBrian K Kobilka
Jul 20, 2012·Nature Chemical Biology·Sébastien Granier, Brian Kobilka
Jan 10, 2013·The Journal of Pharmacology and Experimental Therapeutics·Scott M DeWireJonathan D Violin
Jun 12, 2013·Proceedings of the National Academy of Sciences of the United States of America·Neil T BurfordAndrew Alt
Jun 20, 2013·Proceedings of the National Academy of Sciences of the United States of America·Yinglong MiaoJ Andrew McCammon
Nov 5, 2013·The Journal of Biological Chemistry·Lei ZhouLaura M Bohn
Jan 15, 2014·Nature·Gustavo FenaltiRaymond C Stevens
Feb 17, 2015·Nature Structural & Molecular Biology·Gustavo FenaltiVadim Cherezov
Aug 8, 2015·Nature·Rémy SounierSébastien Granier
Aug 8, 2015·Nature·Weijiao HuangBrian K Kobilka
Sep 9, 2015·Journal of Chemical Information and Modeling·Paola BisignanoMarta Filizola
Mar 8, 2016·Journal of Chemical Theory and Computation·Stefan DoerrGianni De Fabritiis
Aug 18, 2016·Scientific Reports·Katsuya OhbuchiYasuhito Uezono
Aug 18, 2016·Nature·Aashish ManglikBrian K Shoichet

❮ Previous
Next ❯

Citations

Mar 22, 2020·Molecular Pharmacology·Damien JulliéMeritxell Canals
Oct 28, 2019·Biological Psychiatry·Aashish Manglik
Nov 6, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Helmut SchmidhammerMariana Spetea

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiparasitics

Antiparasitics are medications which are indicated for the treatment of parasitic diseases. Discover the latest research on antiparasitics here.